相关实验视频
Updated: Sep 13, 2025

06:01
Transcranial Direct Current Stimulation for Online Gamers
Published on: November 9, 2019
8.1K
针对痴呆症和轻度认知障碍的电子竞技干预:快速范围审查
Dementia and geriatric cognitive disorders
|July 30, 2025
概括
电子竞技干预措施在痴呆症和轻度认知障碍 (MCI) 患者中显示出乐趣的希望,但目前的证据不足以证明临床益处. 需要更严格的试验来评估认知和身体结果.
科学领域:
- 老年病学和康复疗法
- 神经科学与认知健康
- 数字健康与游戏
背景情况:
- 痴呆症和轻度认知障碍 (MCI) 的非药物干预与患者的动机和坚持斗争.
- 电子竞技提供了一个潜在的有吸引力的替代品,但缺乏强有力的证据.
- 本综述映射了电子竞技对痴呆症或MCI患者的干预措施的当前证据.
研究的目的:
- 对诊断为痴呆症或MCI的个人进行电子竞技干预现有研究的快速范围审查.
- 确定和综合有关电子竞技在这个群体中的有效性和安全性的现有证据.
主要方法:
- 根据PRISMA-ScR,Joanna Briggs研究所和Cochrane指南进行快速范围审查.
- 通过六个主要的文献数据库和两个试验注册表进行的搜索,并补充了灰色文献.
- 纳入标准侧重于初级研究,评估痴呆症或MCI患者的电子竞技干预措施.
主要成果:
- 包括6项研究,其中3项是随机对照试验 (干预组中n=84).
- 干预主要使用商业主机上的游戏;样本大小小小 (n=3-23).
- 参与者报告了积极的心理社会效应 (快乐,满意度),但客观的认知或身体效益并未始终被证明,安全监测不一致.
结论:
- 现有的证据不足以支持电子竞技作为痴呆症或MCI的治疗策略.
- 虽然对参与者来说是愉快的,但主观的好处并不等同于临床疗效.
- 在考虑电子竞技作为常规护理之前,需要进行更大规模的,经过良好控制的,具有验证的认知和身体结果的试验.
相关概念视频
Dementia
166
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
166
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
208
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
208
Alzheimer's Disease: Overview
669
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
669

